PATENT CLAIM ANALYSIS

Application Number: 15947983
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "183000"]

Abstract:
The invention provides compositions of novel high penetration compositions (HPC) or high penetration prodrugs (HPP) of antimicrobials and antimicrobial-related compounds, which are capable of crossing biological barriers with high penetration efficiency. The HPCs/HPPs are capable of being converted to parent active drugs or drug metabolites after crossing the biological barrier and thus can render treatments for the conditions that the parent drugs or metabolites can. Additionally, the HPPs are capable of reaching areas that parent drugs may not be able to access or to render a sufficient concentration at the target areas and therefore render novel treatments. The HPCs/HPPs can be administered to a subject through various administration routes, e.g., locally delivered to an action site of a condition with a high concentration or systematically administered to a biological subject and enter the general circulation with a faster rate.

Claim (Index 33):
A pharmaceutical composition comprising a compound according to  claim 30  and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.8642
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13323556', '13550361', '12503739', '15402618', '13732256']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7971531885731779
- 35 USC 102 Novelty (BERT): 0.6362347264653994
- Combined Prediction Score: 0.7810613423624
- Mean Citation Score: 491.28663200000005
- Max Citation Score: 764.9432
- Similarity Product: 536.7643152659894

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test